Welcome to our dedicated page for Lam Research SEC filings (Ticker: LRCX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lam Research Corp. filings document regulatory disclosures for a semiconductor wafer fabrication equipment company. Its Form 8-K reports include operating results and financial-condition updates, material-event disclosures, exhibits for quarterly earnings releases, governance matters, capital-structure items, and changes affecting security-holder rights.
Lam Research proxy and related filings cover annual meeting proposals, director elections, executive compensation advisory votes, stock incentive plan approvals, auditor ratification, charter amendments, stockholder proposals, and changes in the company’s independent registered public accounting firm.
Lam Research Corp executive Christina Correia, the company's CVP and Chief Accounting Officer, reported multiple equity-related transactions dated February 27, 2026. She was granted 1,362 Market-based Performance Restricted Stock Units, which will vest between 0% and 150% on February 27, 2029 based on Lam Research's total shareholder return performance.
She also acquired 3,180 shares of common stock and another 12,979 shares of common stock through restricted stock unit awards. These restricted stock units vest in three installments on February 27, 2027, February 27, 2028, and February 27, 2029, with one award vesting 25%, 25%, and 50% on those dates. Several additional transactions labeled code F represent shares of common stock automatically withheld at a price of $233.89 per share to cover tax withholding obligations upon vesting. After these transactions, Correia directly owned 58,589 shares of common stock, including shares subject to unvested restricted stock units.
LRCX filing dated 03/02/2026 reports proposed sales of common stock by Fidelity Brokerage Services LLC. The notice lists multiple lots totaling examples shown: 6,579, 10,423, and 23,327 shares to be sold.
The filing is a Form 144 notice of intended sale and does not specify transaction proceeds or execution timing.
Fidelity Brokerage Services LLC submitted a Rule 144 notice concerning 4,000 shares of common stock of LRCX. The excerpt lists two tranches of restricted stock vesting recorded as compensation: 03/01/2025 for 2,000 shares and 03/01/2026 for 2,000 shares, with an entry dated 03/02/2026.
Lam Research President and CEO Timothy Archer reported a bona fide gift of 7,080 shares of common stock on February 24, 2026. After this gift, he directly owned 1,196,859 shares, including shares subject to unvested restricted stock units. He also reported indirect holdings of 48,025.775 shares through a 401(k) and 5,670.061 shares through his spouse’s 401(k).
Lam Research Corporation director Eric Brandt reported selling common stock in two transactions. On February 6, 2026, he sold 17,000 shares at $220.95 per share and 18,000 shares at $230 per share.
After these sales, Brandt beneficially owned 253,705 shares of Lam Research common stock directly. This reported amount includes shares that are subject to unvested restricted stock units.
Research Corp director Anirudh Devgan reported receiving 1,141 shares of common stock on February 6, 2026 in a transaction coded “A” at a price of $0 per share, indicating an equity award. The reported amount includes shares subject to unvested restricted stock units.
Following this grant, Devgan beneficially owns 1,141 shares directly and 312 shares indirectly through a trust, reflecting his combined direct and indirect holdings in the company’s common stock.
LAM RESEARCH CORP director Anirudh Devgan amended his initial ownership report, showing two common stock positions as of February 3, 2026. One line reflects 0 shares held directly, while another reflects 312 shares held indirectly through a trust. The entry characterizes these as holdings and does not identify them as explicit purchases or sales.
Form 144 discloses a planned sale of 35,000 shares of common stock through Fidelity Brokerage Services LLC on the NASDAQ exchange. The filing lists an aggregate market value of $7,896,150.00 and an approximate sale date of February 6, 2026.
The seller’s position was acquired via restricted stock vesting from the issuer as compensation, including 32,000 shares on January 27, 2012 and 3,000 shares on January 25, 2013. Shares outstanding were 1,248,771,000 at the time referenced.
Lam Research Chief Financial Officer and EVP Douglas R. Bettinger reported the vesting of equity awards tied to the company’s stock performance. On 02/03/2026, 76,920 shares of common stock were acquired at a price of $0 through a transaction coded “M,” reflecting the settlement of equity-based compensation.
The transaction relates to 51,280 market-based performance restricted stock units granted on 03/01/2023, which vest between 0% and 150% based on Lam Research’s total shareholder return versus a semiconductor index over the 02/01/2023–01/31/2026 performance period. Following this vesting event, Bettinger directly holds 1,064,157 shares of Lam Research common stock, a figure that includes shares subject to unvested restricted stock units.
Lam Research Corporation executive Christina Correia, CVP and Chief Accounting Officer, reported settlement of equity awards tied to company performance. On 02/03/2026, 6,030 market-based performance restricted stock units were exercised, resulting in 9,045 shares of common stock at a price of $0 per share. Following this transaction, she directly beneficially owned 60,637 shares of common stock, and this amount includes shares underlying unvested restricted stock units. The original 6,030-unit performance award was granted on 03/01/2023 and is scheduled to vest between 0% and 150% on 03/01/2026 based on Lam Research total shareholder return relative to the PHLX Semiconductor Total Return Index over the period from 02/01/2023 through 01/31/2026.